The African swine fever vaccine led by Spain would be ready in 2024

Published 2021년 10월 4일

Tridge summary

Europe is planning to have an effective vaccine against African swine fever (ASF) ready by 2024, a disease that poses a significant risk to pig herds globally. The vaccine plans are set to begin in 2024 in Lithuania, Romania, and Kenya, and the project has three vaccine prototypes for wild boar and domestic pigs, with promising results. ASF is a disease that has spread to five continents, and control measures need to be adapted to each country's specific circumstances. The control of wild fauna, biosecurity, and collaboration among administrations and farmers are crucial in addressing this issue.
Disclaimer:The above summary was generated by Tridge's proprietary AI model for informational purposes.

Original content

Europe plans to have an effective vaccine against African swine fever (ASF) ready by 2024, the main health risk for pig herds worldwide. This was confirmed by the professor of the Veterinary Faculty of the Complutense University of Madrid (UCM) José Manuel Sánchez-Vizcaíno, during the official presentation of the results at the First International Workshop for the pig sector, organized by COAG, Coordinadora Europea Vía Campesina and HORIZCIENCE, in Lleida on October 1, within the framework of the European project VACDIVA, which has the collaboration of various entities such as MSD Animal Health. Sánchez-Vizcaíno announced that pilot plans for the African swine fever (ASF) vaccine are expected to begin in 2024 in Lithuania, Romania and Kenya. Likewise, the Spanish researcher is hopeful by the fact that, after long years of investigation of a disease so complex and widespread across the five continents with many variants, at this time, they have three vaccine prototypes for wild ...

Would you like more in-depth insights?

Gain access to detailed market analysis tailored to your business needs.
By clicking “Accept Cookies,” I agree to provide cookies for statistical and personalized preference purposes. To learn more about our cookies, please read our Privacy Policy.